glp 1 dialysis GLP-1 Receptor Agonist Outcomes, Safety, and Body... : Clinical Journal of the American Society of Nephrology Target Trial of Glucagon-Like Peptide-1

The two primary incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) are released from the small intestine after eating

All skin types, especially dull, uneven, or mature skin needing brightening, hydration, and anti-aging care

Glutathione is a "master antioxidant" that protects follicles from damage

CONCLUSIONS In summary, the research progress of GLP-1 in lipid metabolism shows its potential in the treatment of metabolic disorders such as NAFLD, especially combined with its significant weight loss effect, making the application of GLP-1 in obese patients with NAFLD more worthy of in-depth exploration